SCOPE 2025 – Oracle Life Sciences has been recognized as a “Leader” in the Everest Group Life Sciences Clinical Trial Management System (CTMS) Products PEAK Matrix® Assessment 2024, solidifying its position as one of the most innovative companies in clinical trial management.
This recognition highlights Oracle‘s commitment to transforming the clinical trial management sector through advanced, secure, and efficient technological solutions that optimize the work of healthcare systems and the life sciences industry worldwide.
A Comprehensive Platform for Clinical Trial Management
As the life sciences industry faces challenges such as the growing complexity of clinical trials, increased regulations, and the need for real-time data, Oracle has developed solutions that redefine industry standards.
Its Siebel CTMS platform enables:
✅ Integration with Electronic Health Records (EHR), facilitating data flow between researchers, contract research organizations (CROs), and sponsors.
✅ Compatibility with critical systems, such as electronic data capture (EDC), clinical data management systems (CDMS), and electronic trial master files (eTMF).
✅ Compliance with global regulations, ensuring the safety and efficiency of clinical processes.
Oracle, Driving Innovation in Clinical Trial Management
“Being recognized as Leaders by Everest Group reinforces our mission to deliver cutting-edge technology that accelerates innovation and improves outcomes in the life sciences sector,” stated Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences.
Oracle is combining its expertise in data and artificial intelligence to develop platforms specifically designed to meet the challenges of the pharmaceutical industry and healthcare systems. Its CTMS solution strikes a balance between regulatory compliance, security, cost-effectiveness, and global adaptability, enabling organizations to enhance the efficiency and quality of their clinical trials.
An Evolving Market: The Key to Oracle’s Success
According to Nisarg Shah, Practice Director at Everest Group:
“The CTMS market is evolving rapidly due to the increasing complexity of clinical trials, the need for real-time collaboration, and the integration of diverse data sources. Oracle has positioned itself as a key provider by offering a comprehensive, flexible platform that is highly integrated with other clinical and analytical systems.”
The Everest Group report emphasizes that Oracle Siebel CTMS provides a comprehensive solution for clinical trial management, with customization capabilities and a competitive pricing structure. Additionally, its global presence ensures consistent operations across different regions of the world.
What is the PEAK Matrix® Report by Everest Group?
The Everest Group PEAK Matrix® is an evaluation methodology that measures the market success and delivery capabilities of service providers. It is based on two main dimensions:
📌 Market Success: revenue, number of clients, and annual growth.
📌 Delivery Capabilities: operational scope, technology, innovation, coverage, and customer satisfaction.
Evaluated companies are categorized into three groups: Leaders, Major Contenders, and Aspirants.
More Information
Those interested in reading the full report from Everest Group can do so at:
🔗 Everest Group PEAK Matrix® – CTMS 2024
To learn more about Oracle Life Sciences, visit:
🔗 www.oracle.com/lifesciences
With this recognition, Oracle reaffirms its leadership in the digitalization of clinical trials, facilitating efficient data management, process optimization, and accelerating the development of innovative therapies to improve healthcare worldwide.